Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-05-11
1994-11-15
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514338, 514339, 514340, 514397, 546270, 546271, 546273, 548221, 548222, 5483117, 5483121, C07D40112, C07D40312, C07D41112, A61K 3144, A61K 31415, A61K 3142
Patent
active
053648757
ABSTRACT:
Disclosed are imidazoles linked to bicyclic heterocyclic groups, as inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT), processes for their preparation, pharmaceutical compositions, and their use as antihypercholesterolemics and/or antiatherosclerotics.
REFERENCES:
patent: 4228291 (1980-10-01), Durant et al.
patent: 4413130 (1983-10-01), White
patent: 4460598 (1984-07-01), Lautenschlager et al.
patent: 4623662 (1986-11-01), DeVries
patent: 4654358 (1966-03-01), Lautenschlager et al.
patent: 4722927 (1988-02-01), Holmes
patent: 4824843 (1989-04-01), Hoefle et al.
patent: 4868210 (1989-09-01), Trivedi
patent: 4882357 (1989-11-01), Creger et al.
patent: 4900744 (1990-02-01), Billheimer et al.
Ferguson Blair Q.
Kondrad Karen H.
Springer David B.
The Du Pont Merck Pharmaceutical Company
LandOfFree
Imidazoles linked to bicyclic heterocyclic groups for the treatm does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoles linked to bicyclic heterocyclic groups for the treatm, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoles linked to bicyclic heterocyclic groups for the treatm will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1098045